Chemotherapy‐induced peripheral neurotoxicity: a critical analysis
With a 3‐fold increase in the number of cancer survivors noted since the 1970s, there are
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …
now over 28 million cancer survivors worldwide. Accordingly, there is a heightened …
Patient-reported outcomes in the evaluation of toxicity of anticancer treatments
Symptomatic toxicities associated with anticancer treatments, such as nausea and vomiting,
are frequently underreported by clinicians, even when data are prospectively collected …
are frequently underreported by clinicians, even when data are prospectively collected …
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
The standard approach for documenting symptomatic adverse events (AEs) in cancer
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …
clinical trials involves investigator reporting using the National Cancer Institute's (NCI's) …
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
M Di Maio, C Gallo, NB Leighl, MC Piccirillo… - Journal of Clinical …, 2015 - ascopubs.org
Purpose Information about symptomatic toxicities of anticancer treatments is not based on
direct report by patients, but rather on reports by clinicians in trials. Given the potential for …
direct report by patients, but rather on reports by clinicians in trials. Given the potential for …
[HTML][HTML] Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide
Around 60% of people living with cancer are aged 65 years or older. Older cancer patients
face a unique set of age-associated changes, comorbidities and circumstances that impact …
face a unique set of age-associated changes, comorbidities and circumstances that impact …
[HTML][HTML] Strategies for improving the management of immune-related adverse events
With the advent of immunotherapeutic agents, durable and dramatic responses have been
observed in several hard-to-treat malignancies, outlining a roadmap to conquering cancer …
observed in several hard-to-treat malignancies, outlining a roadmap to conquering cancer …
Learning from patients' experiences related to diagnostic errors is essential for progress in patient safety
TD Giardina, H Haskell, S Menon, J Hallisy… - Health …, 2018 - healthaffairs.org
Diagnostic error research has largely focused on individual clinicians' decision making and
system design, while overlooking information from patients. We analyzed a unique new data …
system design, while overlooking information from patients. We analyzed a unique new data …
Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and-29 item short forms among kidney transplant recipients
Abstract Objective The Patient-Reported Outcomes Measurement Information System
(PROMIS) aims to address the lack of generalizable and universal measure of patient …
(PROMIS) aims to address the lack of generalizable and universal measure of patient …
[HTML][HTML] Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment
P Holch, L Warrington, LCA Bamforth, A Keding… - Annals of …, 2017 - Elsevier
Background Significant adverse events (AE) during cancer therapy disrupt treatment and
escalate to emergency admissions. Approaches to improve the timeliness and accuracy of …
escalate to emergency admissions. Approaches to improve the timeliness and accuracy of …
Symptom clusters in head and neck cancer: a systematic review and conceptual model
Objective The two approaches to symptom-cluster research include grouping symptoms and
grouping patients. The objective of this systematic review was to examine the conceptual …
grouping patients. The objective of this systematic review was to examine the conceptual …